Skip to content

    Cancer Health Center

    Font Size
    A
    A
    A

    Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage Information for CNS Embryonal Tumors

    Staging of Medulloblastoma

    Historically, staging was based on an intraoperative evaluation of both the size and extent of the tumor, coupled with postoperative neuroimaging of the brain and spine and cytological evaluation of cerebrospinal fluid (CSF) (the Chang system). Intraoperative evaluation of the extent of the tumor has been supplanted by neuraxis imaging prior to diagnosis and postoperative imaging to determine amount of primary site residual disease. The following tests and procedures are now used for staging:

    Recommended Related to Cancer

    General Information About Esophageal Cancer

    Incidence and Mortality Estimated new cases and deaths from esophageal cancer in the United States in 2014:[1] New cases: 18,170. Deaths: 15,450. The incidence of esophageal cancer has risen in recent decades, coinciding with a shift in histologic type and primary tumor location.[2,3] Adenocarcinoma of the esophagus is now more prevalent than squamous cell carcinoma in the United States and western Europe, with most tumors located in the distal esophagus. The cause for the rising...

    Read the General Information About Esophageal Cancer article > >

    The tumor extent is defined as:

    • M0 -no dissemination.
    • M1 -CSF-positive cytology only.
    • M2 -gross nodular seeding in cerebellar-cerebral subarachnoid space and/or lateral or third ventricle.
    • M3 -gross nodular seeding in spinal subarachnoid space.
    • M4 -extraneural metastasis.

    Postoperative degree of residual disease is designated as:

    • Gross-total resection/near-total resection-no or minimal (not measurable) evidence of residual disease after diagnosis.
    • Subtotal resection-residual disease after diagnosis; this is conventionally further subdivided into less than, greater than, or equal to 1.5 cm2 of measurable residual disease.
    • Biopsy-no tumor resection; only a sample of tumor tissue is removed.

    Since the 1990s, prospective studies have been performed using this staging system to separate patients into average-risk and high-risk medulloblastoma subgroups.[2,3,4]

    The presence of diffuse (>50% of the pathologic specimen) histologic anaplasia has been incorporated as an addition to staging systems. If diffuse anaplasia is found, patients with otherwise average-risk disease are up-staged to high-risk disease.

    Staging of CNS Primitive Neuroectodermal Tumors (PNETs)

    Patients with CNS PNETs are staged in a fashion similar to that used for children with medulloblastoma; however, the patients are not assigned to average-risk and high-risk subgroups for treatment purposes (refer to the Staging of Medulloblastoma section of this summary for more information).

    Staging of Medulloepithelioma and Ependymoblastoma

    Dissemination of both medulloepitheliomas and ependymoblastomas frequently occurs.[5,6] The tumors are staged in the same way as medulloblastoma; however, the patients are not assigned to average-risk and high-risk subgroups for treatment purposes (refer to the Staging of Medulloblastoma section of this summary for more information).

    1 | 2
    Next Article:

    Today on WebMD

    Colorectal cancer cells
    New! I AM Not Cancer Facebook Group
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Ovarian cancer illustration
    Real Cancer Perspectives
     
    Jennifer Goodman Linn self-portrait
    Blog
    what is your cancer risk
    HEALTH CHECK
     
    colorectal cancer treatment advances
    Video
    breast cancer overview slideshow
    SLIDESHOW
     
    prostate cancer overview
    SLIDESHOW
    lung cancer overview slideshow
    SLIDESHOW
     
    ovarian cancer overview slideshow
    SLIDESHOW
    Actor Michael Douglas
    Article